Exploring AI's Practical Application in Drug R&D Regulation
zakkohane · x · 2026-07-16
This piece explores the practical hurdles and transformative role of AI in the regulatory processes of drug research and development. It points out that AI application shouldn't merely be about passing documents between different AI systems; rather, it needs to genuinely address the pain points in regulatory approvals (such as the FDA's IND and NDA).
Related event: Podcast Explores AI's Role in Transforming Drug Regulation(3 posts)→
More from Research
- Stanford Team Introduces Gigatoken, the World's Fastest Tokenizer — StanfordAILab · 2026-07-22
- Tabul AI launches Metal TreeSHAP to speed up Shapley values on Apple silicon — Scobleizer · 2026-07-22
- Reddit points to OpenAI’s ChatGPT Ads page — EcstaticAsparagus509 · 2026-07-22
- Open-source runtime lets each repo define its own AI code reviewer — ibabufrik · 2026-07-22
- DeepSWE: A New Benchmark for Evaluating AI Coding Agents on Real GitHub Issues — pmz · 2026-07-22
- A Rust space-economy sim runs hundreds of autonomous ships, built with Claude — kalcode · 2026-07-22